Cargando…

Quality of life during chemotherapy in lung cancer patients: results across different treatment lines

BACKGROUND: Most lung cancer patients are diagnosed at an advanced disease stage and predominantly receive palliative treatment, which increasingly consists of several chemotherapy lines. We report on patients' quality of life (QOL) to gain knowledge on QOL during and across multiple lines of c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wintner, L M, Giesinger, J M, Zabernigg, A, Sztankay, M, Meraner, V, Pall, G, Hilbe, W, Holzner, B
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2013
Materias:	Clinical Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3817327/ https://www.ncbi.nlm.nih.gov/pubmed/24091620 http://dx.doi.org/10.1038/bjc.2013.585

Ejemplares similares

Quality of life across chemotherapy lines in patients with cancers of the pancreas and biliary tract
por: Zabernigg, August, et al.
Publicado: (2012)

Assessing quality of life on the day of chemotherapy administration underestimates patients’ true symptom burden
por: Giesinger, Johannes M, et al.
Publicado: (2014)

Clinical decision-making and health-related quality of life during first-line and maintenance therapy in patients with advanced non-small cell lung cancer (NSCLC): findings from a real-world setting
por: Sztankay, Monika, et al.
Publicado: (2017)

Evaluating the use of the EORTC patient-reported outcome measures for improving inter-rater reliability of CTCAE ratings in a mixed population of cancer patients: study protocol for a randomized controlled trial
por: Wintner, Lisa M., et al.
Publicado: (2020)

Evaluation of electronic patient-reported outcome assessment with cancer patients in the hospital and at home
por: Wintner, L. M., et al.
Publicado: (2015)

Does the toxicity of endocrine therapy persist into long-term survivorship?: Patient-reported outcome results from a follow-up study beyond a 10-year-survival
por: Carmen, Albertini, et al.
Publicado: (2022)

Monitoring physical and psychosocial symptom trajectories in ovarian cancer patients receiving chemotherapy
por: Meraner, Verena, et al.
Publicado: (2012)

Normative data for the EORTC QLQ-C30 from the Austrian general population
por: Lehmann, Jens, et al.
Publicado: (2020)

Persistent quality of life impairments in differentiated thyroid cancer patients: results from a monitoring programme
por: Gamper, Eva-Maria, et al.
Publicado: (2015)

Improvement of quality of life and psychological distress after inpatient cancer rehabilitation: Results of a longitudinal observational study
por: Riedl, David, et al.
Publicado: (2017)

The effect of chemotherapy on health-related quality of life in mesothelioma: results from the SWAMP trial
por: Arnold, D T, et al.
Publicado: (2015)

Using the Computer-based Health Evaluation System (CHES) to Support Self-management of Symptoms and Functional Health: Evaluation of Hematological Patient Use of a Web-Based Patient Portal
por: Lehmann, Jens, et al.
Publicado: (2021)

Palliative chemotherapy beyond three courses conveys no survival or consistent quality-of-life benefits in advanced non-small-cell lung cancer
por: von Plessen, C, et al.
Publicado: (2006)

How to implement routine electronic patient‐reported outcome monitoring in oncology rehabilitation
por: Wintner, Lisa M., et al.
Publicado: (2020)

Adherence evaluation of endocrine treatment in breast cancer: methodological aspects
por: Oberguggenberger, Anne S, et al.
Publicado: (2012)

Quality of life and sexual function after high-dose or conventional chemotherapy for high-risk breast cancer
por: Malinovszky, K M, et al.
Publicado: (2006)

Phase II study of gemcitabine plus oxaliplatin as first-line chemotherapy for advanced non-small-cell lung cancer
por: Cappuzzo, F, et al.
Publicado: (2005)

Development of an EORTC Quality of Life Module for Renal Cell Cancer Patients: Phase I
por: Wintner, L., et al.
Publicado: (2022)

Non-Cross Resistant Sequential Single Agent Chemotherapy in First-Line Advanced Non-Small Cell Lung Cancer Patients: Results of a Phase II Study
por: Surmont, V., et al.
Publicado: (2009)

Influence of a Structured Exercise Training on Patients Reported Quality of Life in Colorectal Cancer Patients After Adjuvant Chemotherapy: A Pilot Study
por: Piringer, Gudrun, et al.
Publicado: (2020)

International validation of the EORTC QLQ-ELD14 questionnaire for assessment of health-related quality of life elderly patients with cancer
por: Wheelwright, S, et al.
Publicado: (2013)

Serum proteomic test in advanced non-squamous non-small cell lung cancer treated in first line with standard chemotherapy
por: Grossi, F, et al.
Publicado: (2017)

Vinflunine: a new active drug for second-line treatment of advanced breast cancer. Results of a phase II and pharmacokinetic study in patients progressing after first-line anthracycline/taxane-based chemotherapy
por: Campone, M, et al.
Publicado: (2006)

Quality of life and quality-adjusted survival (Q-TWiST) in patients receiving dose-intensive or standard dose chemotherapy for high-risk primary breast cancer
por: Bernhard, J, et al.
Publicado: (2008)

Patients’ and health professionals’ understanding of and preferences for graphical presentation styles for individual-level EORTC QLQ-C30 scores
por: Kuijpers, W., et al.
Publicado: (2015)

Health-related quality of life in patients with metastatic colorectal cancer treated with panitumumab in first- or second-line treatment
por: Bennett, L, et al.
Publicado: (2011)

Health-related quality of life and distress in cancer patients: results from a large randomised study
por: Johansson, B, et al.
Publicado: (2008)

Bilateral Single-Port Sympathectomy: Long-Term Results and Quality of Life
por: Ibrahim, Mohsen, et al.
Publicado: (2013)

Self-reported health-related quality of life is an independent predictor of chemotherapy treatment benefit and toxicity in women with advanced breast cancer
por: Lee, C K, et al.
Publicado: (2010)

Intraarterial chemotherapy as the first-line therapy in penile cancer
por: Chiang, P-H, et al.
Publicado: (2014)

Mitomycin C and Vinorelbine for second-line chemotherapy in NSCLC – a phase II trial
por: Babiak, A, et al.
Publicado: (2007)

International phase IV validation study of an EORTC quality of life questionnaire for testicular cancer patients: the EORTC QLQ-TC26
por: Sztankay, Monika, et al.
Publicado: (2018)

Health-Related Quality of Life and Quality of Sexual Life in Obese Subjects
por: Poggiogalle, Eleonora, et al.
Publicado: (2014)

Multivariate prognostic factors analysis for second-line chemotherapy in advanced biliary tract cancer
por: Fornaro, L, et al.
Publicado: (2014)

Second-line chemotherapy for patients with advanced gastric cancer: who may benefit?
por: Catalano, V, et al.
Publicado: (2008)

The role of haemoglobin level in predicting the response to first-line chemotherapy in advanced colorectal cancer patients
por: Tampellini, M, et al.
Publicado: (2006)

Short-term health-related quality of life consequences in a lung cancer CT screening trial (NELSON)
por: van den Bergh, K A M, et al.
Publicado: (2010)

Variation in the use of chemotherapy in lung cancer
por: Patel, N, et al.
Publicado: (2007)

Thresholds for clinical importance for four key domains of the EORTC QLQ-C30: physical functioning, emotional functioning, fatigue and pain
por: Giesinger, Johannes M., et al.
Publicado: (2016)

Front-line paclitaxel and irinotecan combination chemotherapy in advanced non-small-cell lung cancer: a phase I–II trial
por: Stathopoulos, G P, et al.
Publicado: (2005)

Cannot write session to /tmp/vufind_sessions/sess_t5ht0i5fteevsqcuc3tc9hro47